Neste forelesning fra Masterclass by IFCN holdes den 19/7 2025

Professor Steve Vucic will present: Utility of Threshold tracking TMS in motor neuron disease.
MasterClass Ifcn

 

The Masterclass by IFCN presentations were created in response to a call from IFCN members societies for more high quality, complimentary, online educational content. The series will provide a new presentation every month from top clinical neurophysiologists around the world, and each will include time for discussion with the lecturer following the presentation.

Providing the best in contemporary clinical neurophysiology education delivered in the most optimal format is the primary educational goal of the IFCN. As such, Masterclass by IFCN will be available complimentary to all registrants.

 

The Masterclass by IFCN presentation:

Utility of Threshold tracking TMS in motor neuron disease, 
will take place on Saturday, July 19, 2025 at 8:00 AM (EST).

 

Professor Steve Vucic is the Director of Brain and Nerve Research Centre at Concord Hospital in Sydney, Australia.He also serves as the Northcott Chair of Neurology at the University of Sydney.

Professor Steve Vucic is the Director of Brain and Nerve Research Centre at Concord Hospital in Sydney, Australia.He also serves as the Northcott Chair of Neurology at the University of Sydney.

He will present  Utility of Threshold tracking TMS in motor neuron disease 

Threshold tracking transcranial magnetic stimulation (TMS) is an advanced technique for assessing cortical excitability in the human motor cortex. It has provided key pathophysiological insights in motor neuron disease (MND)/amyotrophic lateral sclerosis (ALS), particularly by confirming cortical hyperexcitability as a central mechanism linked to motor neuron degeneration, disease progression, and clinical presentation. Beyond its research value, threshold tracking TMS has become an important diagnostic tool, allowing for earlier and more accurate diagnosis of ALS/MND. The  recent commercialisation of the threshold tracking  TMS technique (MagXite) has enabled clinical translation. This presentation will explore its pathogenic, prognostic, and diagnostic roles, as well as its growing utility in clinical trials.

 

Register now 

 

 

logo ifcn